Latest news
Panoro Minerals Secures $2 Million from TABB Partners for Sale of Non-Core NSR Asset - Kalkine MediaKalkine Media · Wed, 05 Aug 2026 13:04:00 GMT【Ono Pharmaceutical FY2026 Q1 Earnings Call】Core Operating Profit Up 22.5% to ¥38.7 Billion; Overseas Sales and Royalties Drive Post-Forxiga Revenue Structure, Upside Potential from Weak Yen - finance.biggo.comfinance.biggo.com · Mon, 03 Aug 2026 01:46:00 GMTOno Pharmaceutical : Core profit rose despite lower revenue, driven by royalties and overseas growth - TradingViewTradingView · Fri, 31 Jul 2026 03:02:00 GMT